Skip to main navigation menu Skip to main content Skip to site footer

Vol. 11 No. 05 (2024)
International Multidisciplinary Journal for Research & Development

Articles

LIVER FASCIOLISIS AS A RE-EMERGENCY DISEASE

Published 2024-05-27

  • Turakolov U.N.,Khabibullaev Sh.R.

Turakolov U.N.,Khabibullaev Sh.R.
Center for the development of professional qualification of medical workers. Tashkent, Uzbekistan

Abstract

 Fascioliasis is a helminthiasis that occurs with damage to the hepatobiliary system and is characterized by a long-term chronic course. Pathogens: Fasciola hepatica and Fasciola gigantica. At the stage of sexual maturity, fasciola parasitize humans and many herbivores, including sheep, goats, cattle, and less commonly pigs, horses, and dogs. The lifespan of fasciola in humans reaches 10 years or more. According to WHO, about 2.4 million people are currently affected by fascioliasis, and 180 million people live in areas where there is a high risk of contracting it. The development cycle of the pathogen and the geographic distribution of the disease are described. The pathogenesis of fascioliasis and the clinical picture of the disease are presented. Diagnosis and differential diagnosis of fascioliasis, treatment are described.

Keywords

Liver fascioliasis, fasciola hepatica, parasitic diseases, helminthiases, fascioliasis.

DOWNLOAD PDF CERTIFICATE

References

  1. Kovshirina A.E., Fedorova O.S., Kovshirina Yu.V., Onishchenko S.V., Taslitsky S.S., Katanakhova L.L., Chizhikov A.V., Tataurov I.A., Ogorodova L.M. Analysis of epidemiological studies of the relationship between cholangiocarcinoma and hepatic trematodes. Bulletin of Siberian Medicine. 2020; 19 (1). Р.150–159. https://doi.org: 10.20538/1682-0363-2020-1-150–159.
  2. Seisembayev M.A., Yenin Е.А., Isbambetov А.S., Abdiyev N.М., Birzhanbekov N.N., Yermashov B.Sh., Baktygaliyeva М.А., Issayev М.I., Askeyev B.T. Fasciola hepatica // Bulletin of surgery in Kazakhstan. 2020; №1. С.47-49
  3. Bronshteyn A.M., Malyshev N.A., Fedianina L.V., Davydova I.V. Acute biliary obstruction with cholestasis caused by Fasciola hepatica in a patient travelled to Turcmenistan: a case report and literature review // Epidemiologiya i Infektsionnye Bolezni. (Epidemiology and Infectious Diseases, Russian journal) 2016; 21(2): . (In Russ.). DOI: 10.18821/1560-9529-2016-21-2
  4. Gavrilova E.P. et al. Helminthiases: general chracteristics, diagnostics, treatment // Russian Family Doctor. 2016; 20(4) P.26-34.
  5. Bibik O. I., Arkhipov I. A. Study of triclabendazole effects on Fasciola hepatica’s life-supporting organs, spines and suckers responsible for stable position of the parasite in the host // Rossiyskiy parazitologicheskiy zhurnal = Russian Journal of Parasitology. 2021; 15 (3): 93–100.
  6. Polyakov N. V., Romikh V. V., Polyakov V. E. Fascioloses // Pediatriya = Pediatrics. 2016; 95(2): 167-171.
  7. Nikulina M. A., Khoroshilova I. A., Kiushkina I. N., Arsenyeva I. V. Difficulties in early diagnosis of fascioliasis in humans // Sovremennyye problemy nauki i obrazovaniya = Current issues of science and education. 2016; 6. Available at: https://www. science-education.ru/ru/article/view?id=25839
  8. Nikonorova M.A., Volchkova E.V., Horoshilova I.A., Kiushkina I.N., Arsenyeva I.V., Nemilostiva E.A. The difficulties of early diagnosis of fascioliasis in humans (description of clinical case). Epidemiology and Infectious Diseases. (Epidemiology and Infectious Diseases, Russian journal). 2018; 23(1):44-49. (In Russian). DOI: http://dx.doi.org/10.18821/1560-9529-2018-23-1-44-49.
  9. Aghamolaei, S., Mamaghani, A. J., Ashrafi, K., Kazemi, B., Bandehpour, M., Rouhani, S., Rashidi, S., & Tabaei, S. J. S. (2024). Designing and Developing Serological Test for the Diagnosis of Human Fascioliasis Using a New Recombinant Multi-epitope. Acta parasitologica, 69(1), 1005–1015. https://doi.org/10.1007/s11686-024-00796-0
  10. Bakhshipour, F., Zibaei, M., Rokni, M. B., Miahipour, A., Firoozeh, F., Beheshti, M., Beikzadeh, L., Alizadeh, G., Aryaeipour, M., & Raissi, V. (2024). Comparative evaluation of real-time PCR and ELISA for the detection of human fascioliasis. Scientific reports, 14(1), 3865. https://doi.org/10.1038/s41598-024-54602-y
  11. Çiçek M, Yalçın K, Bilden A, Çakır F, Akpolat N. Evaluation of the seroprevalence and the demographic and clinical findings of fascioliasis patients in the Dicle River Basin in Turkey: A nine-year experience at a university hospital. Eur. Rev. Med. Pharmacol. Sci. 2023;27:10831–10838. doi: 10.26355/eurrev_202311_34449.
  12. Caravedo MA, Cabada MM. Human fascioliasis: Current epidemiological status and strategies for diagnosis, treatment, and control. Res. Rep. Trop. Med. 2020;11:149–158. doi: 10.2147/RRTM.S237461.
  13. Guerrero-Espejo A, Bernad-Anso A. Incidence and geographical distribution of patients hospitalised with fascioliasis in Spain. Enferm Infecc Microbiol. Clin. 2020;38:257–262. doi: 10.1016/j.eimc.2019.08.004.
  14. Aftab, A., Raina, O. K., Maxton, A., & Masih, S. A. (2024). Advances in diagnostic approaches to Fasciola infection in animals and humans: An overviews. Journal of helminthology, 98, e12. https://doi.org/10.1017/S0022149X23000950
  15. Ibrahim, N., Abdel Khalek, E. M., Makhlouf, N. A., Abdel-Gawad, M., Mekky, M., Ramadan, H. K., Abu-Elfatth, A., El-Latif, N. A., Hassan, M. K., Eldeeb, R., Abdelmalek, M., Abd-Elsalam, S., Attia, H., Mohammed, A. Q., Aboalam, H., Farouk, M., & Alboraie, M. (2023). Clinical characteristics of human fascioliasis in Egypt. Scientific reports, 13(1), 16254. https://doi.org/10.1038/s41598-023-42957-7
  16. Gandhi, P., Schmitt, E. K., Chen, C. W., Samantray, S., Venishetty, V. K., & Hughes, D. (2019). Triclabendazole in the treatment of human fascioliasis: a review. Transactions of the Royal Society of Tropical Medicine and Hygiene, 113(12), 797–804. https://doi.org/10.1093/trstmh/trz093
  17. Huang, L., Li, F., Su, H., Luo, J., & Gu, W. (2023). Emerging Human Fascioliasis: A Retrospective Study of Epidemiological Findings in Dali, Yunnan Province, China (2012-2021). Medical science monitor : international medical journal of experimental and clinical research, 29, e940581. https://doi.org/10.12659/MSM.940581
  18. Okasha, H. H., Delsa, H., Gobran, B. A., & Nakhla, R. (2023). Fasciola hepatica: an unusual cause of biliary obstruction. Gastrointestinal endoscopy, 98(4), 660–661. https://doi.org/10.1016/j.gie.2023.06.022
  19. Ton Nu, P. A., Ngo, T. M. C., Nguyen Phuoc, V., Dang Nhu, T., Do Ngoc, A., & Cao, L. C. (2022). Biliary fascioliasis - A rare differential diagnosis of biliary obstruction. Journal of infection in developing countries, 16(10), 1664–1667. https://doi.org/10.3855/jidc.16037
  20. Dolay, K., Hasbahçeci, M., Hatipoğlu, E., Ümit Malya, F., & Akçakaya, A. (2018). Endoscopic diagnosis and treatment of biliary obstruction due to acute cholangitis and acute pancreatitis secondary to Fasciola hepatica infection. Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 24(1), 71–73. https://doi.org/10.5505/tjtes.2017.89490

Downloads

Download data is not yet available.